Abstract
The combination of chemical and biological treatment is a promising solution to remove emerging contaminants, e.g., pharmaceuticals, from wastewater for its future reuse. In this study, the combination of ozonation and ultrasound (O3/US) was examined as a pretreatment prior to membrane bioreactor (MBR). The effects of O3/US on the removal of selected pharmaceuticals, including diclofenac (DCF), sulfamethoxazole (SMX) and carbamazepine (CBZ), and MBR fouling control were investigated. The variation of the toxicity potential of the MBR influent was also assessed. The O3/US treatment was effective in reducing fouling, mainly due to its effects on the microbial metabolism products in the MBR. Extracellular polymeric substance (EPS) concentration was reduced by 50%. Improved operating conditions resulted in higher removal rates for pharmaceuticals in the MBR effluent, with removal efficiency in the range of 80–84%. However, the O3/US treatment alone was not efficient in removing the toxicity of wastewater. This was likely due to the formation of intermediate products that are more toxic than the parent compounds. These intermediate products were observed to be biologically oxidized by MBR, with a 80% reduction of the toxicity potential in the MBR permeate compared to the influent.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Biodeterioration & Biodegradation
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
